(-)-epigallocatechin 3-gallate multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BPNT2 mRNA CTD PMID:22079256 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of IMPAD1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BPNT2 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO BPNT2 (Homo sapiens) 6480464 Estradiol results in increased expression of BPNT2 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BPNT2 mRNA CTD PMID:21570461 and PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Bpnt2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of BPNT2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bpnt2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of BPNT2 mRNA CTD PMID:34747641 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of BPNT2 mRNA CTD PMID:17982090 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of BPNT2 mRNA CTD PMID:26251327 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BPNT2 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BPNT2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO Bpnt2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BPNT2 mRNA CTD PMID:36041667 acrylamide increases expression ISO Bpnt2 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of BPNT2 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of BPNT2 mRNA CTD PMID:19770486 antirheumatic drug increases expression ISO BPNT2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of BPNT2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO BPNT2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of IMPAD1 mRNA CTD PMID:33212167 benzo[a]pyrene increases expression ISO BPNT2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of BPNT2 mRNA CTD PMID:26238291 bisphenol A multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BPNT2 mRNA CTD PMID:28628672 bisphenol A multiple interactions ISO Bpnt2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BPNT2 mRNA CTD PMID:36041667 bisphenol A decreases expression ISO BPNT2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of BPNT2 protein CTD PMID:34186270 bisphenol A increases methylation ISO BPNT2 (Homo sapiens) 6480464 bisphenol A results in increased methylation of BPNT2 gene CTD PMID:31601247 bisphenol A increases expression ISO Bpnt2 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of BPNT2 mRNA CTD PMID:25181051 more ... Bisphenol B increases expression ISO BPNT2 (Homo sapiens) 6480464 bisphenol B results in increased expression of BPNT2 protein CTD PMID:34186270 bisphenol F multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BPNT2 mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO Bpnt2 (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BPNT2 mRNA CTD PMID:36041667 butanal decreases expression ISO BPNT2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of BPNT2 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BPNT2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BPNT2 mRNA CTD PMID:35301059 calciol increases expression EXP 6480464 Cholecalciferol results in increased expression of BPNT2 mRNA CTD PMID:16508948 carbamazepine affects expression ISO BPNT2 (Homo sapiens) 6480464 Carbamazepine affects the expression of BPNT2 mRNA CTD PMID:25979313 CGP 52608 multiple interactions ISO BPNT2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to IMPAD1 gene] CTD PMID:28238834 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of BPNT2 mRNA CTD PMID:37019170 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BPNT2 mRNA CTD PMID:20938992 cisplatin decreases expression ISO BPNT2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of BPNT2 mRNA CTD PMID:27594783 cytarabine decreases expression ISO BPNT2 (Homo sapiens) 6480464 Cytarabine results in decreased expression of BPNT2 mRNA CTD PMID:21198554 dexamethasone multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BPNT2 mRNA more ... CTD PMID:28628672 dorsomorphin multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO BPNT2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of BPNT2 mRNA CTD PMID:29803840 ethyl methanesulfonate decreases expression ISO BPNT2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of BPNT2 mRNA CTD PMID:23649840 flutamide increases expression ISO Bpnt2 (Rattus norvegicus) 6480464 Flutamide results in increased expression of BPNT2 mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of IMPAD1 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO BPNT2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of BPNT2 mRNA CTD PMID:23649840 gentamycin decreases expression ISO Bpnt2 (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of BPNT2 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO BPNT2 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of BPNT2 mRNA CTD PMID:20044591 indometacin multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BPNT2 mRNA more ... CTD PMID:28628672 ivermectin decreases expression ISO BPNT2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of BPNT2 protein CTD PMID:32959892 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BPNT2 mRNA CTD PMID:20938992 methapyrilene decreases expression ISO Bpnt2 (Rattus norvegicus) 6480464 Methapyrilene results in decreased expression of BPNT2 mRNA CTD PMID:30467583 N-acetyl-1,4-benzoquinone imine affects response to substance ISO BPNT2 (Homo sapiens) 6480464 BPNT2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine CTD PMID:21177773 nefazodone increases expression ISO Bpnt2 (Rattus norvegicus) 6480464 nefazodone results in increased expression of BPNT2 mRNA CTD PMID:24136188 nickel atom increases expression ISO BPNT2 (Homo sapiens) 6480464 Nickel results in increased expression of BPNT2 mRNA CTD PMID:24768652 and PMID:25583101 paracetamol decreases expression ISO BPNT2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of BPNT2 mRNA CTD PMID:22230336 paracetamol increases expression ISO Bpnt2 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of IMPAD1 mRNA CTD PMID:33387578 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of BPNT2 mRNA CTD PMID:17562736 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of BPNT2 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO BPNT2 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of BPNT2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BPNT2 mRNA CTD PMID:27188386 potassium chromate multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BPNT2 mRNA CTD PMID:22079256 potassium chromate increases expression ISO BPNT2 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of BPNT2 mRNA CTD PMID:22079256 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of BPNT2 mRNA CTD PMID:21278054 resveratrol multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of BPNT2 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of BPNT2 mRNA CTD PMID:19073995 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of BPNT2 mRNA CTD PMID:21795629 and PMID:30953684 sodium arsenite decreases expression ISO BPNT2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of BPNT2 mRNA CTD PMID:22714537 sodium arsenite increases expression ISO BPNT2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of BPNT2 mRNA CTD PMID:28595984 succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BPNT2 mRNA CTD PMID:26378955 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of BPNT2 mRNA CTD PMID:27339419 and PMID:31919559 thioacetamide increases expression ISO Bpnt2 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of BPNT2 mRNA CTD PMID:34492290 trichloroethene decreases expression ISO Bpnt2 (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of BPNT2 mRNA CTD PMID:33387578 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of BPNT2 mRNA CTD PMID:19042947 troglitazone decreases expression EXP 6480464 Troglitazone results in decreased expression of BPNT2 mRNA CTD PMID:28973697 valproic acid affects expression ISO BPNT2 (Homo sapiens) 6480464 Valproic Acid affects the expression of BPNT2 mRNA CTD PMID:25979313 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of BPNT2 mRNA CTD PMID:17292431 valproic acid affects splicing ISO Bpnt2 (Rattus norvegicus) 6480464 Valproic Acid affects the splicing of BPNT2 mRNA CTD PMID:29427782 valproic acid increases expression ISO BPNT2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of BPNT2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO BPNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BPNT2 mRNA CTD PMID:27188386 vinclozolin affects expression ISO Bpnt2 (Rattus norvegicus) 6480464 vinclozolin affects the expression of BPNT2 mRNA CTD PMID:19015723
